ArticleAmerican journal of translational research2023
Correlation between the expression of CD24 on circulating tumor cells and prognosis in breast cancer.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 9 citations in OpenAlex.
- Redefining cancer care: harnessing circulating tumor cells' potential for improved diagnosis and prognosis.Cancer cell international · 2025Review
- CD24 flags anastasis in melanoma cells.Apoptosis : an international journal on programmed cell death · 2025Article
- Decoding CD24: Roles of chemoradiotherapy resistance and potential as therapeutic targets.Oncology research · 2025Review
- Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).Breast cancer research and treatment · 2024Review
- EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.Scientific reports · 2024Article
- Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.Cancer immunology, immunotherapy : CII · 2024Review
- New insights into the correlations between circulating tumor cells and target organ metastasis.Signal transduction and targeted therapy · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the expression of tumor stem cell marker CD24 in peripheral blood circulating tumor cells (CTCs) of breast cancer and the value of CTCs in predicting the prognosis of breast cancer patients.
methodsClinical data of 102 breast cancer patients from January 2015 to December 2019 were retrospectively collected. CTC test results, CD24 test results, tumor size, tumor stage, pathological type, molecular type, lymph node metastasis, survival time, and survival status of patients were collected. The correlation between the expression of CD24 in peripheral blood CTCs of breast cancer and the survival time of patients was analyzed.
resultsEpithelial-CTCs were closely related to estrogen receptor (ER) expression (
conclusionThe positive expression of CD24 in CTC is closely related to TNM stage, lymph node metastasis, and tumor size in breast cancer patients. The positive expression of CD24 in CTCs, especially in mixed-CTCs, may be one of the prognostic indicators for patients with early and intermediate stage breast cancer.
Indexed as
Identifiers
37056857PMC10086875W4365479025What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.